249 related articles for article (PubMed ID: 29275930)
1. Ovarian sex cord-stromal tumours: an update in recent molecular advances.
Lim D; Oliva E
Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
[TBL] [Abstract][Full Text] [Related]
2. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
3. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
[TBL] [Abstract][Full Text] [Related]
5. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
6. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
Kommoss F; Lehr HA
Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
[TBL] [Abstract][Full Text] [Related]
7. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
8. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract][Full Text] [Related]
9. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Clin Lab Med; 2023 Jun; 43(2):245-274. PubMed ID: 37169445
[TBL] [Abstract][Full Text] [Related]
10. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Surg Pathol Clin; 2022 Jun; 15(2):235-258. PubMed ID: 35715160
[TBL] [Abstract][Full Text] [Related]
11. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
12. Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.
Meurgey A; Descotes F; Mery-Lamarche E; Devouassoux-Shisheboran M
Virchows Arch; 2017 Feb; 470(2):225-229. PubMed ID: 27830327
[TBL] [Abstract][Full Text] [Related]
13. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
[TBL] [Abstract][Full Text] [Related]
14. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
15. Genetics and genomics of ovarian sex cord-stromal tumors.
Fuller PJ; Leung D; Chu S
Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Characterization of 120 Testicular Sex Cord-Stromal Tumors With an Emphasis on the Diagnostic Utility of SOX9, FOXL2, and SF-1.
Lau HD; Kao CS; Williamson SR; Cheng L; Ulbright TM; Idrees MT
Am J Surg Pathol; 2021 Oct; 45(10):1303-1313. PubMed ID: 34232606
[TBL] [Abstract][Full Text] [Related]
18. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
[TBL] [Abstract][Full Text] [Related]
19. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
Buza N; Wong S; Hui P
Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
[TBL] [Abstract][Full Text] [Related]
20. Ovarian sex cord-stromal tumours and their mimics.
Young RH
Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]